Low GSK-3 activity in frontal cortex of schizophrenic patients
- 3 October 2001
- journal article
- Published by Elsevier in Schizophrenia Research
- Vol. 52 (1-2) , 101-105
- https://doi.org/10.1016/s0920-9964(00)00174-2
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Glycogen Synthase Kinase-3β Facilitates Staurosporine- and Heat Shock-induced ApoptosisJournal of Biological Chemistry, 2000
- Neurodevelopmental abnormalities in schizophrenia: insights from neuropathology.Development and Psychopathology, 1999
- Abnormalities of Wnt signalling in schizophrenia – evidence for neurodevelopmental abnormalityNeuroReport, 1998
- Alterations in hippocampal non-phosphorylated MAP2 protein expression in schizophreniaBrain Research, 1997
- The Neurodevelopmental Theory of Schizophrenia: Evidence Concerning Structure and NeuropsychologyAnnals of Medicine, 1996
- Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenicsBiological Psychiatry, 1993
- Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia.Proceedings of the National Academy of Sciences, 1991
- Some Cytoarchitectural Abnormalities of the Entorhinal Cortex in SchizophreniaArchives of General Psychiatry, 1991
- Hippocampal Pyramidal Cell Orientation in SchizophreniaArchives of General Psychiatry, 1987
- Schizophrenia and the Hippocampus: The Embryological Hypothesis ExtendedSchizophrenia Bulletin, 1987